Glasgow Clinical Trials Unit

SOPs Guidelines
Title Number Version Release Date
Portfolio Therapy Areas 52.002A 2.0 14/07/16
UK Study-Wide Governance Report 52.002B 1.0 14/07/16
R&D Amendment Checklist 52.003A 4.0 14/07/16
Amendment Approval Email Category A or B 52.003B 3.0 25/08/22
Amendment Approval/Acknowledgement Emails - Substantial Amendment 52.003C 2.0 14/07/16
Amendment Approval/Acknowledgement Emails - Substantial Amendment & Protocol Amendment 52.003D 2.0 14/07/16
Amendment Acknowledgment Email 52.003E 1.0 25/08/22
Contact Review Checklist 52.004A 1.0 10/03/23
Letter Template - Honorary Research Contract 52.005A 2.0 14/07/16
Letter Template - Letter of Access 52.005B 2.0 14/07/16
Letter Template - Letter of Access (Staff Studies Only) 52.005C 2.0 14/07/16
Letter Template - Letter of Access (NHS to NHS) 52.005D 2.0 14/07/16
Imaging Research - Research Trial Imaging Details 52.007A 2.0 14/07/16
Sample Email of Notification to Head of Clinical Department or Clinical Service Manager 52.007B 1.0 14/07/16
Checklist of Documents Required for R&D Submission 52.009A 5.0 14/07/16
Investigator Submission Email 52.009B 3.0 14/07/16
Template e-Folder 52.009C 2.0 14/07/16
Project e-File Checklist 52.009D 13.0 25/08/22
GMO Contained Use Regulations 52.013A 1.0 13/02/20
GMO Deliberate Release 52.013B 1.0 13/02/20
GMO Trials 52.013C 1.0 13/02/20
Categorisation of Phase I (FIH) Trial 52.015A 1.0 14/08/19
Phase I Risk Assessment 52.015B 1.0 14/08/19
Phase I and High Risk Reviewers Comments 52.015C 1.0 14/08/19
Phase I or High Risk Committees Combined Review 52.015D 1.0 15/08/19